A new series of pyrazolo[3,4-d]pyrimidines has been synthesized. The new compounds were tested for their antitumor activity on 60 different cell lines, and some of the compounds were found to have potent antitumor activity. In particular, 2-hydroxybenzaldehyde [1-(4-chlorophenyl)-3-methyl-1H-pyrazolo-[3,4-d]pyrimidin-4-yl]hydrazone (VIIa) was found to be the most effective among the other derivatives, showing IC50 values of 0.326 to 4.31 μM on 57 different cell lines.
Synthesis of Novel Pyrazolo[3,4-d]pyrimidine Derivatives as Potential anti-BreastCancer Agents. -Novel pyrazolo[3,4-d]pyrimidine derivatives (IV) are synthesized and screened for their cytotoxic activity against the human breast cancer cell line MCF7. Most of these compounds exhibit potent antitumor activity comparable to that of doxorubicin. Compound (IVc) is found to be the most active substance in the series. -(ABD EL HAMID, M. K.; MIHOVILOVIC, M. D.; EL-NASSAN*, H. B.; Eur. J. Med. Chem. 57 (2012) 323-328, http://dx.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.